Bioavailable Testosterone(ng/ml) | SHBG (nmol/l) | |||||
Variable | Absent | Present | P Value | Absent | Present | P Value |
ATP III | ||||||
Abdominal Obesity-WC | 13.44 ± 3.12 | 6.65 ± 1.32 | 0.2151 | 3.58 ± 1.07 | 3.10 ± 1.06 | 0.6493 |
Raised FBG | 10.32 ± 2.04 | 6.73 ± 1.51 | 0.3865 | 3.87 ± 1.05 | 3.15 ± 1.02 | 0.3328 |
Raised TG | 15.45 ± 3.22 | 9.88 ± 2.10 | 0.0033 | 3.16 ± 1.19 | 2.29 ± 0.62 | 0.0124 |
Raised BP | 11.38 ± 3.36 | 6.50 ± 2.39 | 0.5395 | 3.45 ± 1.02 | 4.63 ± 1.27 | 0.0762 |
Reduced HDL-C | 7.48 ± 1.33 | 4.53 ± 1.86 | 0.5322 | 3.57 ± 1.06 | 3.68 ± 1.06 | 0.3852 |
IDF | ||||||
Abdominal Obesity-WC | 10.34 ± 2.43 | 5.45 ± 1.33 | 0.4642 | 4.22 ± 1.47 | 3.54 ± 1.08 | 0.1433 |
Raised FBG | 10.25 ± 2.38 | 6.62 ± 1.34 | 0.3865 | 3.78 ± 1.37 | 3.47 ± 1.43 | 0.3562 |
Raised TG | 15.31 ± 4.33 | 10.38 ± 2.19 | 0.0039 | 3.25 ± 1.09 | 2.54 ± 0.63 | 0.0024 |
Raised BP | 5.31 ± 1.66 | 7.29 ± 2.45 | 0.7513 | 3.98 ± 1.01 | 3.87 ± 1.03 | 0.3591 |
Reduced HDL-C | 8.30 ± 2.39 | 4.36 ± 1.48 | 0.3702 | 3.86 ± 1.07 | 3.78 ± 1.06 | 0.6802 |
WHO | ||||||
Central Obesity-WHR | 8.36 ± 2.32 | 5.54 ± 1.75 | 0.4370 | 5.23 ± 1.47 | 4.44 ± 1.34 | 0.0432 |
Raised FBG | 10.37 ± 3.53 | 6.48 ± 1.33 | 0.3865 | 4.15 ± 1.52 | 3.98 ± 1.02 | 0.5722 |
Dyslipidemia | 8.52 ± 2.33 | 6.56 ± 1.54 | 0.7121 | 3.63 ± 1.16 | 2.00 ± 0.43 | 0.1739 |
Raised BP | 9.35 ± 2.73 | 8.78 ± 1.43 | 0.4985 | 4.63 ± 1.58 | 5.25 ± 1.44 | 0.2634 |